IM Cannabis Corp. Logo

IM Cannabis Corp.

IMCC.CN

(1.0)
Stock Price

3,00 CAD

-52.18% ROA

-90.37% ROE

-0.24x PER

Market Cap.

4.888.847,00 CAD

60.94% DER

0% Yield

-24.73% NPM

IM Cannabis Corp. Stock Analysis

IM Cannabis Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

IM Cannabis Corp. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.4x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a reasonable amount of debt compared to its ownership (64%), suggesting a balanced financial position and a moderate level of risk.

3 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

4 ROE

Negative ROE (-58.71%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-44.52%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-2) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

IM Cannabis Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

IM Cannabis Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

IM Cannabis Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

IM Cannabis Corp. Revenue
Year Revenue Growth
1996 1.100.000
1997 600.000 -83.33%
1998 100.000 -500%
1999 100.000 0%
2000 110.892 9.82%
2001 34.583 -220.65%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2019 9.074.000 100%
2020 15.890.000 42.89%
2021 54.300.000 70.74%
2022 54.335.000 0.06%
2023 152.424.000 64.35%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

IM Cannabis Corp. Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 139.431 100%
2009 0 0%
2010 3.639 100%
2011 1.358 -167.97%
2012 1.120 -21.25%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2019 233.000 100%
2020 136.000 -71.32%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

IM Cannabis Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 1.288.029 100%
2009 1.272.709 -1.2%
2010 528.132 -140.98%
2011 502.833 -5.03%
2012 254.238 -97.78%
2013 205.543 -23.69%
2015 0 0%
2016 0 0%
2017 124.905 100%
2019 9.099.000 98.63%
2020 14.795.000 38.5%
2021 39.690.000 62.72%
2022 24.096.000 -64.72%
2023 32.096.000 24.93%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

IM Cannabis Corp. EBITDA
Year EBITDA Growth
1996 1.100.000
1997 600.000 -83.33%
1998 100.000 -500%
1999 100.000 0%
2000 110.892 9.82%
2001 34.583 -220.65%
2002 -1.023.462 103.38%
2003 176.554 679.69%
2004 -420.897 141.95%
2005 79.007 632.73%
2006 -156.927 150.35%
2007 -356.901 56.03%
2008 -1.534.515 76.74%
2009 -1.307.563 -17.36%
2010 -658.710 -98.5%
2011 -507.734 -29.74%
2012 9.459.392 105.37%
2013 -186.668 5167.5%
2015 -43.956 -324.67%
2016 -15.250 -188.24%
2017 -124.970 87.8%
2019 -2.389.000 94.77%
2020 -7.038.000 66.06%
2021 -10.636.000 33.83%
2022 -12.373.000 14.04%
2023 -22.860.000 45.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

IM Cannabis Corp. Gross Profit
Year Gross Profit Growth
1996 1.100.000
1997 600.000 -83.33%
1998 100.000 -500%
1999 100.000 0%
2000 110.892 9.82%
2001 34.583 -220.65%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2019 3.929.000 100%
2020 10.468.000 62.47%
2021 10.296.000 -1.67%
2022 9.162.000 -12.38%
2023 36.020.000 74.56%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

IM Cannabis Corp. Net Profit
Year Net Profit Growth
1996 -900.000
1997 -1.100.000 18.18%
1998 -1.800.000 38.89%
1999 -900.000 -100%
2000 -637.703 -41.13%
2001 -868.200 26.55%
2002 -1.023.462 15.17%
2003 -666.175 -53.63%
2004 -5.214 -12676.66%
2005 -836.566 99.38%
2006 -611.371 -36.83%
2007 -762.399 19.81%
2008 -1.414.259 46.09%
2009 -1.324.125 -6.81%
2010 -669.181 -97.87%
2011 -519.773 -28.74%
2012 -5.374.053 90.33%
2013 -228.344 -2253.49%
2015 -45.613 -400.61%
2016 -15.750 -189.61%
2017 -124.970 87.4%
2019 -7.419.000 98.32%
2020 -28.734.000 74.18%
2021 -18.518.000 -55.17%
2022 -24.921.000 25.69%
2023 -24.836.000 -0.34%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

IM Cannabis Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 -360
1997 -440 18.18%
1998 -700 37.14%
1999 -240 -191.67%
2000 -165 -46.34%
2001 -142 -16.31%
2002 -142 0%
2003 -76 -85.53%
2004 -1 0%
2005 -73 100%
2006 -42 -75.61%
2007 -39 -7.89%
2008 -51 24%
2009 -39 -31.58%
2010 -16 -137.5%
2011 -12 -33.33%
2012 -124 90.32%
2013 -5 -3000%
2015 -1 0%
2016 0 0%
2017 -2 100%
2019 -2 0%
2020 -7 71.43%
2021 -3 -133.33%
2022 -3 0%
2023 -2 -200%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

IM Cannabis Corp. Free Cashflow
Year Free Cashflow Growth
2003 -392.610
2004 -339.599 -15.61%
2005 -296.459 -14.55%
2006 -464.795 36.22%
2007 -2.319.602 79.96%
2008 -3.659.255 36.61%
2009 -1.135.089 -222.38%
2010 -700.584 -62.02%
2011 -784.871 10.74%
2012 -493.300 -59.11%
2013 -82.884 -495.17%
2015 -26.596 -211.64%
2016 0 0%
2017 -96.144 100%
2019 -7.506.000 98.72%
2020 -10.629.000 29.38%
2021 -38.967.000 72.72%
2022 -14.202.000 -174.38%
2023 5.355.000 365.21%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

IM Cannabis Corp. Operating Cashflow
Year Operating Cashflow Growth
2003 -290.233
2004 -313.913 7.54%
2005 -290.098 -8.21%
2006 -386.294 24.9%
2007 -433.971 10.99%
2008 -1.171.366 62.95%
2009 -527.852 -121.91%
2010 -632.559 16.55%
2011 -434.090 -45.72%
2012 -218.720 -98.47%
2013 -82.884 -163.89%
2015 -26.596 -211.64%
2016 0 0%
2017 -96.144 100%
2019 -5.959.000 98.39%
2020 -7.919.000 24.75%
2021 -34.372.000 76.96%
2022 -12.640.000 -171.93%
2023 5.355.000 336.04%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

IM Cannabis Corp. Capital Expenditure
Year Capital Expenditure Growth
2003 102.377
2004 25.686 -298.57%
2005 6.361 -303.8%
2006 78.501 91.9%
2007 1.885.631 95.84%
2008 2.487.889 24.21%
2009 607.237 -309.71%
2010 68.025 -792.67%
2011 350.781 80.61%
2012 274.580 -27.75%
2013 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2019 1.547.000 100%
2020 2.710.000 42.92%
2021 4.595.000 41.02%
2022 1.562.000 -194.17%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

IM Cannabis Corp. Equity
Year Equity Growth
2003 772.973
2004 1.017.649 24.04%
2005 819.270 -24.21%
2006 1.446.522 43.36%
2007 2.389.102 39.45%
2008 6.356.801 62.42%
2009 8.938.859 28.89%
2010 8.845.352 -1.06%
2011 8.664.115 -2.09%
2012 3.336.865 -159.65%
2013 3.214.948 -3.79%
2015 11.392.497 71.78%
2016 11.376.747 -0.14%
2017 -456.842 2590.3%
2019 26.109.000 101.75%
2020 12.610.000 -107.05%
2021 204.945.000 93.85%
2022 23.797.000 -761.22%
2023 19.794.000 -20.22%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

IM Cannabis Corp. Assets
Year Assets Growth
2003 881.916
2004 1.148.324 23.2%
2005 1.102.306 -4.17%
2006 1.674.275 34.16%
2007 2.849.214 41.24%
2008 6.408.628 55.54%
2009 9.822.855 34.76%
2010 9.688.794 -1.38%
2011 9.708.665 0.2%
2012 92.162 -10434.35%
2013 28.730 -220.79%
2015 276 -10309.42%
2016 276 0%
2017 9.143 96.98%
2019 30.894.000 99.97%
2020 38.116.000 18.95%
2021 287.388.000 86.74%
2022 60.676.000 -373.64%
2023 52.365.000 -15.87%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

IM Cannabis Corp. Liabilities
Year Liabilities Growth
2003 108.943
2004 130.675 16.63%
2005 283.036 53.83%
2006 227.753 -24.27%
2007 460.112 50.5%
2008 51.827 -787.78%
2009 883.996 94.14%
2010 68.194 -1196.3%
2011 269.302 74.68%
2012 250.507 -7.5%
2013 321.742 22.14%
2015 416.398 22.73%
2016 432.148 3.64%
2017 465.985 7.26%
2019 4.785.000 90.26%
2020 25.506.000 81.24%
2021 82.443.000 69.06%
2022 36.879.000 -123.55%
2023 32.571.000 -13.23%

IM Cannabis Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
6.23
Net Income per Share
-1.54
Price to Earning Ratio
-0.24x
Price To Sales Ratio
0.06x
POCF Ratio
-0.45
PFCF Ratio
-0.44
Price to Book Ratio
0.24
EV to Sales
0.19
EV Over EBITDA
-1.34
EV to Operating CashFlow
-1.47
EV to FreeCashFlow
-1.38
Earnings Yield
-4.22
FreeCashFlow Yield
-2.27
Market Cap
0,00 Bil.
Enterprise Value
0,02 Bil.
Graham Number
7.24
Graham NetNet
-1.16

Income Statement Metrics

Net Income per Share
-1.54
Income Quality
0.26
ROE
-0.9
Return On Assets
-0.37
Return On Capital Employed
-0.78
Net Income per EBT
0.96
EBT Per Ebit
1.07
Ebit per Revenue
-0.24
Effective Tax Rate
0.02

Margins

Sales, General, & Administrative to Revenue
0.3
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.24
Operating Profit Margin
-0.24
Pretax Profit Margin
-0.26
Net Profit Margin
-0.25

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.82
Free CashFlow per Share
-0.88
Capex to Operating CashFlow
0.07
Capex to Revenue
-0.01
Capex to Depreciation
-0.2
Return on Invested Capital
-0.58
Return on Tangible Assets
-0.52
Days Sales Outstanding
68.48
Days Payables Outstanding
57.99
Days of Inventory on Hand
66.73
Receivables Turnover
5.33
Payables Turnover
6.29
Inventory Turnover
5.47
Capex per Share
-0.06

Balance Sheet

Cash per Share
0,10
Book Value per Share
1,51
Tangible Book Value per Share
0.38
Shareholders Equity per Share
1.51
Interest Debt per Share
3.1
Debt to Equity
0.61
Debt to Assets
0.22
Net Debt to EBITDA
-0.91
Current Ratio
1.01
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.61
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.29
Average Receivables
0,01 Bil.
Average Payables
0,01 Bil.
Average Inventory
12757500
Debt to Market Cap
2.39

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

IM Cannabis Corp. Dividends
Year Dividends Growth

IM Cannabis Corp. Profile

About IM Cannabis Corp.

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

CEO
Mr. Oren Shuster
Employee
283
Address
Kibbutz Glil Yam
Tel Aviv, 4690500

IM Cannabis Corp. Executives & BODs

IM Cannabis Corp. Executives & BODs
# Name Age
1 Advocate Michal Lebovitz Nissimov
General Counsel
70
2 Mr. Uri Birenberg
Chief Financial Officer
70
3 Mr. Marc Lustig M.B.A., M.Sc.
Executive Chairman
70
4 Mr. Oren Shuster
Chief Executive Officer & Director
70
5 Mr. Richard Balla
Chief Executive Officer & Director of German Operations – Adjupharm GmbH
70
6 Mr. Michael Ruscetta
Chief Executive Officer of Trichome Financial Corporation
70
7 Mr. Howard Steinberg C.F.A.
Chief Executive Officer of TJAC & MYM
70
8 Ms. Rinat Efrima
Chief Executive Officer of IMC Holdings Ltd.
70

IM Cannabis Corp. Competitors